Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinclair Aesthetics, operating in China as Sinclair (Shanghai) Medical Technology Co., Ltd., is a leading medical aesthetics company and a wholly-owned subsidiary of Huadong Medicine. The company specializes in the development and commercialization of minimally invasive aesthetic treatments, including collagen stimulators, dermal fillers, and thread lifts. Its flagship product, Ellansé, is a polycaprolactone-based filler that has gained significant market share in China since its approval in 2021. Sinclair's portfolio also includes the Maili hyaluronic acid filler range, Silhouette Soft suspension threads, and Lanluma PLLA fillers. The company leverages Huadong Medicine's extensive distribution network to expand its footprint across the Asia-Pacific region. Sinclair is positioned as a high-end provider in the rapidly evolving global medical beauty sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Xinke Li Aesthetics.